SLGL
Sol-Gel Technologies Ltd

1,115
Mkt Cap
$113.35M
Volume
22,838.00
52W High
$52.26
52W Low
$4.02
PE Ratio
-13.15
SLGL Fundamentals
Price
$42.42
Prev Close
$40.69
Open
$41.96
50D MA
$35.72
Beta
0.52
Avg. Volume
15,716.22
EPS (Annual)
-$3.80
P/B
4.54
Rev/Employee
$339,352.94
Loading...
Loading...
News
all
press releases
Sol-Gel Technologies (NASDAQ:SLGL) Issues Quarterly Earnings Results
Sol-Gel Technologies (NASDAQ:SLGL - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($2.13) earnings per share for the quarter, missing analysts' consensus...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Sol-Gel Technologies (SLGL) to Release Quarterly Earnings on Friday
Sol-Gel Technologies (NASDAQ:SLGL) will be releasing its Q3 2025 earnings before the market opens on Friday, November 21. (View Earnings Report at...
MarketBeat·14d ago
News Placeholder
Yelin Lapidot Holdings Management Ltd. Lowers Stock Position in Sol-Gel Technologies Ltd. $SLGL
Yelin Lapidot Holdings Management Ltd. decreased its position in Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Free Report) by 92.2% in the second quarter, according to its most recent Form 13F filing...
MarketBeat·21d ago
News Placeholder
Sol-Gel Stock Tumbles Over Underwhelming Q1 Earnings: Retail Stays Pessimistic
The company’s diluted loss per share came in at $3.2, exceeding an estimated loss of $1.2.
Stocktwits·6mo ago
News Placeholder
Sol-Gel Technologies Announces Key Shareholder Decisions
Sol-Gel Technologies (SLGL) has released an update. Shareholders of Sol-Gel Technologies Ltd., a company based in Ness Ziona, Israel, have recently...
TipRanks Financial Blog·1y ago
News Placeholder
Sol-Gel Announces Executive Changes Amid Growth
Sol-Gel Technologies (SLGL) has released an update. Sol-Gel Technologies, a dermatology company known for its innovative skin treatments and FDA-ap...
TipRanks Financial Blog·1y ago
News Placeholder
Sol-Gel Technologies Announces Leadership Changes
Sol-Gel Technologies (SLGL) has released an update. Sol-Gel Technologies Ltd., an innovative dermatology company, announced a management realignmen...
TipRanks Financial Blog·1y ago
News Placeholder
Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve Cream
Patent challenge initiated by Arcutis BiotherapeuticsNESS ZIONA, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company pioneering treatments...
Globe Newswire·2y ago
News Placeholder
Sol-Gel Technologies collaboration partner first-to-file ANDA generic to Zoryve
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Sol-Gel Technologies reports 2023 EPS ($1.01) vs. (65c) last year
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest SLGL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.